These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12030895)
1. Presence of the d8/17 B-cell marker in children with rheumatic fever in Israel. Harel L; Zeharia A; Kodman Y; Straussberg R; Zabriskie JB; Amir J Clin Genet; 2002 Apr; 61(4):293-8. PubMed ID: 12030895 [TBL] [Abstract][Full Text] [Related]
2. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. Khanna AK; Buskirk DR; Williams RC; Gibofsky A; Crow MK; Menon A; Fotino M; Reid HM; Poon-King T; Rubinstein P J Clin Invest; 1989 May; 83(5):1710-6. PubMed ID: 2785121 [TBL] [Abstract][Full Text] [Related]
3. Presence of D8/17 B-cell marker in patients with poststreptococcal reactive arthritis. Harel L; Mukamel M; Zeharia A; Kodman Y; Prais D; Uziel Y; Zabriskie JB; Amir J Rheumatol Int; 2007 Jun; 27(8):695-8. PubMed ID: 17221172 [TBL] [Abstract][Full Text] [Related]
4. Ethnic differences in expression of susceptibility marker(s) in rheumatic fever/rheumatic heart disease patients. Kaur S; Kumar D; Grover A; Khanduja KL; Kaplan EL; Gray ED; Ganguly NK Int J Cardiol; 1998 Mar; 64(1):9-14. PubMed ID: 9579811 [TBL] [Abstract][Full Text] [Related]
5. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Murphy TK; Goodman WK; Fudge MW; Williams RC; Ayoub EM; Dalal M; Lewis MH; Zabriskie JB Am J Psychiatry; 1997 Mar; 154(3):402-7. PubMed ID: 9054790 [TBL] [Abstract][Full Text] [Related]
6. B-cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings. Harrington Z; Visvanathan K; Skinner NA; Curtis N; Currie BJ; Carapetis JR Med J Aust; 2006 May; 184(10):507-10. PubMed ID: 16719750 [TBL] [Abstract][Full Text] [Related]
7. Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients. Hoekstra PJ; Bijzet J; Limburg PC; Steenhuis MP; Troost PW; Oosterhoff MD; Korf J; Kallenberg CG; Minderaa RB Am J Psychiatry; 2001 Apr; 158(4):605-10. PubMed ID: 11282696 [TBL] [Abstract][Full Text] [Related]
8. A rapid test for the detection of a B-cell marker (D8/17) in rheumatic fever patients. Herdy GV; Zabriskie JB; Chapman F; Khanna A; Swedo S Braz J Med Biol Res; 1992; 25(8):789-94. PubMed ID: 1342610 [TBL] [Abstract][Full Text] [Related]
9. Distribution of cells bearing B-cell alloantigen(s) in North Indian rheumatic fever/rheumatic heart disease patients. Kumar D; Kaul P; Grover A; Ganguly NK Mol Cell Biochem; 2001 Feb; 218(1-2):21-6. PubMed ID: 11330833 [TBL] [Abstract][Full Text] [Related]
10. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Swedo SE; Leonard HL; Mittleman BB; Allen AJ; Rapoport JL; Dow SP; Kanter ME; Chapman F; Zabriskie J Am J Psychiatry; 1997 Jan; 154(1):110-2. PubMed ID: 8988969 [TBL] [Abstract][Full Text] [Related]
11. D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette's disorder. Weisz JL; McMahon WM; Moore JC; Augustine NH; Bohnsack JF; Bale JF; Johnson MB; Morgan JF; Jensen J; Tani LY; Veasy LG; Hill HR Clin Diagn Lab Immunol; 2004 Mar; 11(2):330-6. PubMed ID: 15013984 [TBL] [Abstract][Full Text] [Related]
12. Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa. Walker KG; Cooper M; McCabe K; Hughes J; Mathiassen W; Lawrenson J; Wilmshurst JM Cardiol Young; 2011 Jun; 21(3):328-33. PubMed ID: 21303578 [TBL] [Abstract][Full Text] [Related]
13. D8/17 expression on B lymphocytes in anorexia nervosa. Sokol MS; Ward PE; Tamiya H; Kondo DG; Houston D; Zabriskie JB Am J Psychiatry; 2002 Aug; 159(8):1430-2. PubMed ID: 12153841 [TBL] [Abstract][Full Text] [Related]
14. Frequency of D8/17 B lymphocyte alloantigen in north Indian patients with rheumatic heart disease. Ganguly NK; Anand IS; Koicha M; Jindal S; Wahi PL Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():9-14. PubMed ID: 1639437 [TBL] [Abstract][Full Text] [Related]
15. An easy method for detection of rheumatic antigen(s) in rheumatic fever/rheumatic heart disease patients by dot-ELISA. Kumar D; Kaur S; Grover A; Singal PK; Ganguly NK Can J Cardiol; 1998 Jun; 14(6):807-10. PubMed ID: 9676165 [TBL] [Abstract][Full Text] [Related]
18. [Presence of a non-HLA antigen in B-lymphocytes from patients with rheumatic fever and their relatives defined using monoclonal antibodies]. Rodríguez RS; Ontiveros P; Torres S; Khanna AK; Buskirk DR; Zabriskie JB Bol Med Hosp Infant Mex; 1990 May; 47(5):313-7. PubMed ID: 2390184 [TBL] [Abstract][Full Text] [Related]
19. Further observations and characterization of monoclonal antibodies reacting with B cell alloantigens associated with rheumatic fever and rheumatic heart disease. Kumar D; Kaur S; Grover A; Bali H; Khanduja KL; Kaplan EL; Gray ED; Ganguly NK J Lab Clin Med; 2000 Mar; 135(3):287-93. PubMed ID: 10711868 [TBL] [Abstract][Full Text] [Related]
20. [The diagnostic significance of the surface B-cell marker carrier state in arthritis and other manifestations of rheumatic fever]. Shostak NA Ter Arkh; 1991; 63(5):49-52. PubMed ID: 1887418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]